Russ Smith shares a new column by John Mac Ghlionn about digital dealers cashing in on demand for body-changing drugs.
Recap by typeshit. Post by Russ Smith on X.
The EMA's CHMP amended its type 2 diabetes indication, and Italian diabetologists say Italy could be the first European country to offer the once-weekly combo.
26:19
A personal update from TakingWeightOff on life after stopping tirzepatide, three weeks in, and what caught them off guard.
Nyah Phengsitthy reports Lilly is staking out a new battlefront around an unapproved obesity treatment. The full story has the details.
A history of drug advertising, from opium-laced tonics and Radithor to the 1938 law after Elixir Sulfanilamide killed over 100 people. Semaglutide is mostly a hook.
Survey data on 3,615 US adults showed about 30% lower odds of GLP-1 use among cancer survivors, despite more heart and kidney disease. Causes remain unclear.
A woman with bipolar disorder developed tremor and slurred speech three weeks into Zepbound. An outside expert advises checking lithium levels early, not avoiding the drugs.
Loading…